BrightSpring Health Services (BTSG) EBITDA (2023 - 2026)

BrightSpring Health Services (BTSG) has reported EBITDA for 4 consecutive years, with $130.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA rose 168.53% year-over-year to $130.4 million; the trailing twelve-month figure through Jun 2026 stood at $447.8 million (up 143.46% YoY), and the FY2025 full-year result was $295.3 million, up 173.5% from the prior year.
• EBITDA advanced to $130.4 million in Q2 2026 per BTSG's latest filing, from $121.4 million in the prior quarter.
• Across five years, EBITDA topped out at $130.4 million in Q2 2026 and bottomed at -$52.3 million in Q3 2023.
• Historically, EBITDA has averaged $50.9 million across 4 years, with a median of $51.1 million in 2023.
• The sharpest annual moves came in 2024 and 2025: EBITDA sank 129.74% in 2024, then soared 430.87% in 2025.
• Over 4 years, EBITDA stood at -$20.8 million in 2023, then surged by 367.1% to $55.5 million in 2024, then soared by 94.66% to $108.1 million in 2025, then increased by 20.61% to $130.4 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $130.4 million, $121.4 million, and $108.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.